ASH 2014: The management of CLL

Dr George Follows provides an overview of results of clinical trials in chronic lymphocytic leukemia (CLL) presented at the 2014 American Society of Hematology (ASH) Annual Meeting. He considers the clinical value of maintenance therapy with anti-CD20 monoclonal antibodies in CLL and molecularity defined subtypes in CLL.

Share this video